Answers are grounded in this paper and cite their sources.
Six of seven patients with Raynaud's disease were subjectively benefited by the administration of fine-particle griseofulvin in dosages of 500 or 1,000 mg daily. Objective improvement was determined by measuring the digital temperature response following a one-minute exposure of the digit to stirred ice water maintained at 0 C. The temperature curves following griseofulvin therapy showed a much more rapid recovery toward normal when compared to the original baseline curves, and, in most instances, approached the mean control curve of 14 normal subjects.
No takes yet. Share an insight, caveat, or question.
C. Robert Charles (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: